Page 96 - 《中国药房》2025年9期

MASCC and ESMO guideline update for the prevention blind，phase Ⅲ trial of fosaprepitant for cancer patients
of chemotherapy- and radiotherapy-induced nausea and treated with high-dose cisplatin[J]. Cancer Commun
vomiting and of nausea and vomiting in advanced cancer （Lond），2023，43（2）：246-256.
patients[J]. Ann Oncol，2016，27（Suppl. 5）：v119-v133. [16] HU Z H，LIANG W H，YANG Y P，et al. Personalized es‐
[ 4 ] BLOECHL-DAUM B，DEUSON R R，MAVROS P，et al. timate of chemotherapy-induced nausea and vomiting：de‐
Delayed nausea and vomiting continue to reduce patients’ velopment and external validation of a nomogram in can‐
quality of life after highly and moderately emetogenic che‐ cer patients receiving highly/moderately emetogenic che‐
motherapy despite antiemetic treatment[J]. J Clin Oncol， motherapy[J]. Medicine （Baltimore），2016，95（2）：e2476.
2006，24（27）：4472-4478. [17] MOSA A S M，HOSSAIN A M，YOO I. A dynamic predic‐
[ 5 ] AAPRO M，CAPRARIU Z，CHILINGIROV P，et al. tion engine to prevent chemotherapy-induced nausea and
Assessing the impact of antiemetic guideline compliance vomiting[J]. Artif Intell Med，2020，109：101925.
on prevention of chemotherapy-induced nausea and vomi- [18] ZHOU Y W，HE Y Q，YANG H，et al. Development and
ting：results of the nausea/emesis registry in oncology validation a nomogram for predicting the risk of severe
（NERO）[J]. Eur J Cancer，2022，166：126-133. COVID-19：a multi-center study in Sichuan，China[J].
[ 6 ] MOLASSIOTIS A，STAMATAKI Z，KONTOPANTELIS PLoS One，2020，15（5）：e0233328.
E. Development and preliminary validation of a risk pre‐ [19] BABA Y，BABA H，YAMAMOTO S，et al. Chemotherapy-
diction model for chemotherapy-related nausea and vomi- induced nausea and vomiting is less controlled at delayed
ting[J]. Support Care Cancer，2013，21（10）：2759-2767. phase in patients with esophageal cancer：a prospective
[ 7 ] SIMINO G P R，REIS I A，ACURCIO F A，et al. Risk fac‐ registration study by the CINV Study Group of Japan[J].
Dis Esophagus，2017，30（2）：1-7.
tors associated with antineoplastic chemotherapy-induced
[20] BOURDEANU L，FRANKEL P，YU W，et al. Chemo-
nausea and vomiting[J]. Rev Saude Publica，2020，54：106.
therapy-induced nausea and vomiting in Asian women
[ 8 ] GARUFFO L，LEONI A，GATTA R，et al. The applica‐
tions of machine learning in the management of patients with breast cancer receiving anthracycline-based adjuvant
chemotherapy[J]. J Support Oncol，2012，10（4）：149-154.
undergoing stem cell transplantation：are we ready? [J].
[21] KENNEDY S K F，GOODALL S，LEE S F，et al. 2020
Cancers （Basel），2025，17（3）：395.
ASCO，2023 NCCN，2023 MASCC/ESMO，and 2019
[ 9 ] DOKNIĆ I，MITROVIĆ M，BUKUMIRIĆ Z，et al. The
CCO：a comparison of antiemetic guidelines for the treat‐
comparison of classical statistical and machine learning
ment of chemotherapy-induced nausea and vomiting in
methods in prediction of thrombosis in patients with acute
cancer patients[J]. Support Care Cancer，2024，32（5）：280.
myeloid leukemia[J]. Bioengineering （Basel），2025，
12（1）：63. [22] WARR D. Prognostic factors for chemotherapy-induced
nausea and vomiting[J]. Eur J Pharmacol，2014，722：
[10] 中国抗癌协会癌症康复与姑息治疗专业委员会，中国抗
192-196.
癌协会肿瘤临床化疗专业委员会，中国抗癌协会肿瘤支
[23] MOLASSIOTIS A，LEE P H，BURKE T A，et al. Anticipa‐
持治疗专业委员会，等. 中国抗肿瘤治疗相关恶心呕吐
tory nausea，risk factors，and its impact on chemotherapy-
预防和治疗指南：2023 版[J]. 中华肿瘤杂志，2024，46
induced nausea and vomiting：results from the pan European
（6）：481-501.
emesis registry study[J]. J Pain Symptom Manage，2016，
[11] MANDREKAR J N. Receiver operating characteristic
51（6）：987-993.
curve in diagnostic test assessment[J]. J Thorac Oncol，
[24] 孙博，刘丹娜，刘勋，等. 帕洛诺司琼联合地塞米松预防
2010，5（9）：1315-1316.
化疗所致恶心呕吐失败的危险因素探索[J]. 中国药房，
[12] VAN CALSTER B，MCLERNON D J，VAN SMEDEN
2021，32（21）：2640-2646.
M，et al. Calibration：the Achilles heel of predictive analy- [25] MOLASSIOTIS A，YAM B C，YUNG H，et al. Pretreat‐
tics[J]. BMC Med，2019，17（1）：230. ment factors predicting the development of postchemo‐
[13] STEYERBERG E W，VICKERS A J，COOK N R，et al. therapy nausea and vomiting in Chinese breast cancer pa‐
Assessing the performance of prediction models：a frame‐ tients[J]. Support Care Cancer，2002，10（2）：139-145.
work for traditional and novel measures[J]. Epidemiology， [26] YAP K Y，LOW X H，CHUI W K，et al. Computational
2010，21（1）：128-138. prediction of state anxiety in Asian patients with cancer
[14] VICKERS A J，ELKIN E B. Decision curve analysis：a susceptible to chemotherapy-induced nausea and vomiting
novel method for evaluating prediction models[J]. Med [J]. J Clin Psychopharmacol，2012，32（2）：207-217.
Decis Making，2006，26（6）：565-574. [27] SATNY M，HUBACEK J A，VRABLIK M. Statins and in‐
[15] ZHAO Y Y，ZHAO B，CHEN G，et al. Validation of dif- flammation[J]. Curr Atheroscler Rep，2021，23（12）：80.
ferent personalized risk models of chemotherapy-induced （收稿日期：2024-10-29 修回日期：2025-03-26）
nausea and vomiting：results of a randomized，double- （编辑：陈 宏）

· 1110 · China Pharmacy 2025 Vol. 36 No. 9 中国药房 2025年第36卷第9期